日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Structure and immunological activity of QS-21 variant from Quillaja saponaria aerial biomass.

皂树地上生物质中 QS-21 变体的结构和免疫活性。

San Martín Ricardo, Liu Yuzhong, Yang Yihan, Fox Christopher B, Iyer L Ravi, Mohamath Raodoh, Ramer-Denisoff Gabi, Kinsey Robert, Guderian Jeffrey A, Schwabach Jessica, Deng Siwen, Fernandes Natalia de Andrade Teixeira, Radke Clayton

Kilo-Scale GMP Synthesis of Renewable Semisynthetic Vaccine-Grade Squalene

千克级GMP可再生半合成疫苗级角鲨烯的合成

Fisher, Karl J; Shirtcliff, Laura; Buchanan, Greg; Thompson, Andrew W; Woolard, Frank X; LaMunyon, Donald H; Marshall, Jonathan L; Baranouskas, Maya B; Voelker, Rodger B; Lusk, Jason S; Wells, Charles E; Mohamath, Raodoh; Kinsey, Robert; Lykins, William R; Ramer-Denisoff, Gabi; Fox, Christopher B; Paddon, Christopher J; McPhee, Derek

Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M-052 liposomes): In vitro characterization

含佐剂(LecA + GLA-3 M-052 脂质体)的合成溶组织内阿米巴疫苗的鼻内递送:体外表征

Murphy, Brynn M; Chen, John Z; Rolo, Michael; Eldam, Mohamed; Jordan, Lynn; Sivananthan, Sandra J; Kinsey, Robert; Guderian, Jeffrey A; Pedersen, Karl; Abhyankar, Mayuresh; Petri, William A; Fox, Christopher B; Finlay, Warren H; Vehring, Reinhard; Martin, Andrew R

Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy.

利用实验设计策略优化多组分鼻内溶组织内阿米巴疫苗制剂

Abhyankar Mayuresh M, Orr Mark T, Kinsey Robert, Sivananthan Sandra, Nafziger Andrew J, Oakland David N, Young Mary K, Farr Laura, Uddin Md Jashim, Leslie Jhansi L, Burgess Stacey L, Liang Hong, De Lima Ines, Larson Elise, Guderian Jeffrey A, Lin Susan, Kahn Aaron, Ghosh Prakash, Reed Sierra, Tomai Mark A, Pedersen Karl, Petri William A Jr, Fox Christopher B